Cargando…

Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner

INTRODUCTION: Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharqawi, Abdallah, Drye, Naomi, Shugaba, Abdul, O’reilly, Alison, Kadry, Ahmed M., El-Sakka, A I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148493/ https://www.ncbi.nlm.nih.gov/pubmed/37118694 http://dx.doi.org/10.1186/s12894-023-01241-6

Ejemplares similares

The Impact of Prostate Imaging Reporting and Data System Version 2.1 and Prostate-Specific Antigen Density in the Prediction of Clinically Significant Prostate Cancer
por: Tezcan, Sehnaz, et al.
Publicado: (2023)

Effects of Dynamic Contrast Enhancement on Transition Zone Prostate Cancer in Prostate Imaging Reporting and Data System Version 2.1
por: Zhang, Jiahui, et al.
Publicado: (2023)

Reliability of Stereotactic Coordinates of 1.5-Tesla and 3-Tesla MRI in Radiosurgery and Functional Neurosurgery
por: Kim, Hae Yu, et al.
Publicado: (2014)

Prostate Imaging-Reporting and Data System: Comparison of the Diagnostic Performance between Version 2.0 and 2.1 for Prostatic Peripheral Zone
por: Kim, Hyun Soo, et al.
Publicado: (2021)

Diffusion-Weighted Imaging of a Prostate Cancer Xenograft Model Seen on a 7 Tesla Animal MR Scanner: Comparison of ADC Values and Pathologic Findings
por: Jung, Dae Chul, et al.
Publicado: (2012)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer
por: Rudolph, Madhuri Monique, et al.
Publicado: (2020)

1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer
por: POPITA, CRISTIAN, et al.
Publicado: (2017)

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy
por: Fujimoto, Ayumi, et al.
Publicado: (2023)

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
por: Lei, Yin, et al.
Publicado: (2022)

Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
por: Johnston, Thomas J., et al.
Publicado: (2017)

Elastography in the Urological Practice: Urinary and Male Genital Tract, Prostate Excluded—Review
por: Simon, Vasile, et al.
Publicado: (2022)

The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version
por: Hong, Jeong Hee, et al.
Publicado: (2006)

Inter-reader agreement of the prostate imaging reporting and data system version v2.1 for detection of prostate cancer: A systematic review and meta-analysis
por: Wen, Jing, et al.
Publicado: (2022)

Use of a 1.0 Tesla open scanner for cardiovascular magnetic resonance evaluation of pediatric and congenital heart disease
por: Lu, Jimmy C, et al.
Publicado: (2015)

Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2
por: Tewes, Susanne, et al.
Publicado: (2016)

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study)
por: Di Franco, Florian, et al.
Publicado: (2023)

Reliability and validity of intraoral and extraoral scanners
por: Jacob, Helder B., et al.
Publicado: (2015)

Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2
por: Feng, Zhao-Yan, et al.
Publicado: (2016)

Use of a 1.0 Tesla open scanner for evaluation of pediatric and congenital heart disease: a retrospective cohort study
por: Lu, Jimmy C, et al.
Publicado: (2015)

Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image–based post-implant dosimetry of prostate brachytherapy
por: Watanabe, Kenta, et al.
Publicado: (2019)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
por: Gao, Lin-Rui, et al.
Publicado: (2023)

Cardiovascular magnetic resonance imaging produces highly reproducible rodent cardiac volumetric and functional data using a 1.5 Tesla scanner
por: Kumarasinghe, Gayathri, et al.
Publicado: (2016)

Edema is not a reliable diagnostic sign to exclude small brain metastases
por: Schneider, Tanja, et al.
Publicado: (2017)

The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
por: Chevalier, Simone, et al.
Publicado: (2015)

Excluded
por: Asai, David
Publicado: (2020)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
por: Mussi, Thais Caldara, et al.
Publicado: (2016)

Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer
por: Somanath, Payaningal R., et al.
Publicado: (2023)

Welcome to the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound with a 1.5 Tesla Scanner: A Prospective Intraindividual Comparison Study of Intraoperative Imaging
por: Gagliardo, Cesare, et al.
Publicado: (2021)

Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
por: Glicksman, Rachel M., et al.
Publicado: (2023)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
por: Qalawena, Muhammed M., et al.
Publicado: (2020)

CORE COmpendium of RElations: version 2.1
por: Borodulin, V I, et al.
Publicado: (1995)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Reliability-centered maintenance 2.1
por: Moubray, John
Publicado: (1999)

Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection
por: Park, Sung Yoon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fmmu9vmkkvub4qbga1svjr7abs